AIP
Ameritas Investment Partners Portfolio holdings
AUM
$3.17B
1-Year Return
20.23%
This Quarter Return
+2.59%
1 Year Return
+20.23%
3 Year Return
+87.65%
5 Year Return
+163.29%
10 Year Return
+366.97%
AUM
$2.91B
AUM Growth
-$2.79M
(-0.1%)
Cap. Flow
-$28.7M
Cap. Flow
% of AUM
-0.99%
Top 10 Holdings %
Top 10 Hldgs %
20.73%
Holding
3,313
New
249
Increased
388
Reduced
954
Closed
189
Top Buys
| 1 |
First Trust Preferred Securities and Income ETF
FPE
|
$6.6M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$3.33M |
| 3 |
Sarepta Therapeutics
SRPT
|
$3.18M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
$3.12M |
| 5 |
RB Global
RBA
|
$2.98M |
Top Sells
| 1 |
Vistra
VST
|
$6.09M |
| 2 |
Global X US Preferred ETF
PFFD
|
$5.96M |
| 3 |
GoDaddy
GDDY
|
$5.3M |
| 4 |
iShares S&P 500 Growth ETF
IVW
|
$4.3M |
| 5 |
Super Micro Computer
SMCI
|
$4.19M |
Sector Composition
| 1 | Technology | 21.87% |
| 2 | Industrials | 10.05% |
| 3 | Consumer Discretionary | 9.49% |
| 4 | Financials | 8.93% |
| 5 | Healthcare | 8.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Paychex
PAYX
$48.7B
| $1.68M | 0.06% |
14,176
-91
| -0.6% | -$10.8K |
|
377
SPDR S&P Biotech ETF
XBI
$5.39B
| $1.67M | 0.06% |
18,055
| – | – |
|
378
RBC Bearings
RBC
$12.2B
| $1.67M | 0.06% |
6,176
-246
| -4% | -$66.4K |
|
379
SPDR Portfolio S&P 500 Growth ETF
SPYG
$40.8B
| $1.66M | 0.06% |
20,706
+3,415
| +20% | +$274K |
|
380
Neogen
NEOG
$1.25B
| $1.65M | 0.06% |
105,876
-2,208
| -2% | -$34.5K |
|
381
Target
TGT
$42.3B
| $1.65M | 0.06% |
11,137
-213
| -2% | -$31.5K |
|
382
Autoliv
ALV
$9.58B
| $1.65M | 0.06% |
15,404
-815
| -5% | -$87.2K |
|
383
COPT Defense Properties
CDP
$3.46B
| $1.65M | 0.06% |
65,739
-1,982
| -3% | -$49.6K |
|
384
Duolingo
DUOL
$12.4B
| $1.64M | 0.06% |
7,875
+4,913
| +166% | +$1.03M |
|
385
Commault Systems
CVLT
$7.96B
| $1.64M | 0.06% |
13,507
-608
| -4% | -$73.9K |
|
386
Morningstar
MORN
$10.8B
| $1.64M | 0.06% |
5,546
-205
| -4% | -$60.6K |
|
387
Ashland
ASH
$2.51B
| $1.64M | 0.06% |
17,362
-385
| -2% | -$36.4K |
|
388
Qualys
QLYS
$4.87B
| $1.64M | 0.06% |
11,495
-395
| -3% | -$56.3K |
|
389
Willis Towers Watson
WTW
$32.1B
| $1.63M | 0.06% |
6,223
+5
| +0.1% | +$1.31K |
|
390
Maximus
MMS
$4.97B
| $1.62M | 0.06% |
18,908
-661
| -3% | -$56.6K |
|
391
Uber
UBER
$190B
| $1.61M | 0.06% |
22,183
-270
| -1% | -$19.6K |
|
392
H&R Block
HRB
$6.85B
| $1.61M | 0.06% |
29,678
-1,089
| -4% | -$59.1K |
|
393
FTI Consulting
FCN
$5.46B
| $1.61M | 0.06% |
7,461
-219
| -3% | -$47.2K |
|
394
Axalta
AXTA
$6.89B
| $1.6M | 0.06% |
46,931
-1,663
| -3% | -$56.8K |
|
395
Cadence Bank
CADE
$7.04B
| $1.6M | 0.06% |
56,705
-2,086
| -4% | -$59K |
|
396
Ingredion
INGR
$8.24B
| $1.6M | 0.06% |
13,963
-431
| -3% | -$49.4K |
|
397
NOV
NOV
$4.95B
| $1.6M | 0.05% |
84,130
-2,849
| -3% | -$54.2K |
|
398
Archer Daniels Midland
ADM
$30.2B
| $1.6M | 0.05% |
26,386
+1,279
| +5% | +$77.3K |
|
399
Eagle Materials
EXP
$7.86B
| $1.59M | 0.05% |
7,327
-270
| -4% | -$58.7K |
|
400
Idexx Laboratories
IDXX
$51.4B
| $1.59M | 0.05% |
3,267
-40
| -1% | -$19.5K |
|